Compile Data Set for Download or QSAR
Report error Found 127 Enz. Inhib. hit(s) with all data for assayid = 1 entry = 11889
Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657796BDBM657796(US20240083872, Compound I-109)
Affinity DataKi:  0.430nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657790BDBM657790(US20240083872, Compound I-086)
Affinity DataKi:  0.503nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657801BDBM657801(US20240083872, Compound I-123)
Affinity DataKi:  0.506nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657797BDBM657797(US20240083872, Compound I-110)
Affinity DataKi:  0.537nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657795BDBM657795(US20240083872, Compound I-107)
Affinity DataKi:  0.549nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657792BDBM657792(US20240083872, Compound I-102)
Affinity DataKi:  0.642nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657791BDBM657791(US20240083872, Compound I-101)
Affinity DataKi:  0.683nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657784BDBM657784(US20240083872, Compound I-031)
Affinity DataKi:  0.709nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657798BDBM657798(US20240083872, Compound I-117)
Affinity DataKi:  0.820nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657800BDBM657800(US20240083872, Compound I-122)
Affinity DataKi:  0.824nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657794BDBM657794(US20240083872, Compound I-104)
Affinity DataKi:  0.952nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657779BDBM657779(US20240083872, Compound I-006)
Affinity DataKi:  0.968nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657799BDBM657799(US20240083872, Compound I-118)
Affinity DataKi:  1.03nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657802BDBM657802(US20240083872, Compound I-126)
Affinity DataKi:  1.24nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657793BDBM657793(US20240083872, Compound I-103)
Affinity DataKi:  1.89nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657787BDBM657787(US20240083872, Compound I-043)
Affinity DataKi:  2.14nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657783BDBM657783(US20240083872, Compound I-030)
Affinity DataKi:  2.17nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657789BDBM657789(US20240083872, Compound I-084)
Affinity DataKi:  2.61nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657788BDBM657788(US20240083872, Compound I-046)
Affinity DataKi:  3.09nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657785BDBM657785(US20240083872, Compound I-033)
Affinity DataKi:  4.01nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657782BDBM657782(US20240083872, Compound I-029)
Affinity DataKi:  4.33nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657778BDBM657778(US20240083872, Compound I-004)
Affinity DataKi:  4.51nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657786BDBM657786(US20240083872, Compound I-037)
Affinity DataKi:  4.70nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657780BDBM657780(US20240083872, Compound I-012)
Affinity DataKi:  6.02nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657527BDBM657527(US20240083872, Compound I-003)
Affinity DataKi:  9.93nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657887BDBM657887(US20240083872, Compound I-099)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657886BDBM657886(US20240083872, Compound I-098)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657889BDBM657889(US20240083872, Compound I-105)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657888BDBM657888(US20240083872, Compound I-100)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657882BDBM657882(US20240083872, Compound I-094)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657885BDBM657885(US20240083872, Compound I-097)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657884BDBM657884(US20240083872, Compound I-096)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657895BDBM657895(US20240083872, Compound I-114)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657894BDBM657894(US20240083872, Compound I-113)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657897BDBM657897(US20240083872, Compound I-116)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657896BDBM657896(US20240083872, Compound I-115)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657891BDBM657891(US20240083872, Compound I-108)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657890BDBM657890(US20240083872, Compound I-106)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657893BDBM657893(US20240083872, Compound I-112)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657892BDBM657892(US20240083872, Compound I-111)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657871BDBM657871(US20240083872, Compound I-081)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657870BDBM657870(US20240083872, Compound I-080)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657867BDBM657867(US20240083872, Compound I-077)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657866BDBM657866(US20240083872, Compound I-076)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657869BDBM657869(US20240083872, Compound I-079)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657868BDBM657868(US20240083872, Compound I-078)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657879BDBM657879(US20240083872, Compound I-091)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657878BDBM657878(US20240083872, Compound I-090)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657881BDBM657881(US20240083872, Compound I-093)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandChemical structure of BindingDB Monomer ID 657880BDBM657880(US20240083872, Compound I-092)
Affinity DataKi: <10nMAssay Description:Binding Test of the Compound According to the Present Invention: In advance, 0.5 μL of the compound solution dissolved in DMSO was dispensed int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2024
Entry Details
US Patent

Displayed 1 to 50 (of 127 total ) | Next | Last >>
Jump to: